How The Leaked TPP ISDS Chapter Threatens Intellectual Property Limitations and Exceptions 26/03/2015 by Intellectual Property Watch 6 Comments By Prof. Sean Flynn, Associate Director, Program on Information Justice and Intellectual Property (PIJIP), American University Washington College of Law Reposted with permission from Infojustice.org, original here. I released a statement earlier today opining that the today’s leak of the Investor State Dispute Settlement (ISDS) chapter proposed for the Trans Pacific Partnership (TPP) agreement (available […]
Indian Draft Pesticides Bill Contains TRIPS-Plus Data Exclusivity, Indian Pharma Says 26/03/2015 by Catherine Saez, Intellectual Property Watch 3 Comments India is considering legislation on pesticides containing data exclusivity provisions that would raise the level of intellectual property protection above the minimum required by international trade agreements and could act as a precursor for pharmaceutical products in the country, a leading Indian industry representative warned this week. India is sensitive to restrictions on the use of marketing data of patented pharmaceuticals as it is seen as the world leader in generic medicines, which use such data.
Slifer Named USPTO Deputy Director 25/03/2015 by Intellectual Property Watch Leave a Comment A veteran technology industry and innovation patent attorney has been named the new deputy director has been named at the United States Patent and Trademark Office (USPTO).
Patent On Conventional Plant Dismissed For Lack Of Novelty, Firm Says 24/03/2015 by Intellectual Property Watch Leave a Comment The District Court of The Hague (Netherlands) ruled last week that a patent for red radish plants is invalid in the Netherlands for lack of novelty but did not rule on the fact that the particular plant was bred using essential biological processes. The case, between two Dutch companies, related to red radish sprouts on which one company held a patent.
Open Source Model In Computers Should Be Applied To Genomic Data, Paper Says 22/03/2015 by Intellectual Property Watch Leave a Comment Genomic data should be made publicly available for the promotion of science as a global public good, a new paper argues. Two researchers suggest that a model inspired by the open-source computer software movement should be developed for plant breeding, animal breeding, and biomedicine.
EU Trade Commissioner Suggests Special Court For ISDS Cases 18/03/2015 by Intellectual Property Watch Leave a Comment European Union Trade Commissioner Cecilia Malmstroem today defended the inclusion of investor-state dispute settlement panels in the Transatlantic Trade and Investment Partnership (TTIP), but offered several amendments for consideration.
Central European Countries Establish Visegrad Patent Institute To Reduce Costs, Facilitate Applications 18/03/2015 by Jaroslaw Adamowski for Intellectual Property Watch 1 Comment WARSAW – In a move towards increased regional cooperation in the field of intellectual property, Poland, Hungary, Slovakia and the Czech Republic have signed an agreement to set up the Visegrad Patent Institute (VPI). And representatives of the parties to the agreement say that their ambitions reach further, towards ensuring the recently-established body becomes a regional hub for patent cooperation in Central-Eastern Europe.
CJEU Renders Landmark Decision On Private Copying Levies 16/03/2015 by William New, Intellectual Property Watch Leave a Comment From Hogan Lovells: Private copying levies in the Member States have occupied the Court of Justice of the European Union (CJEU) quite a few times, previously for example in decision C‑521/11 from 2013. With the current decision in Nokia vs. Copydan Båndkopi (C‑463/12), the CJEU answers some of the most discussed questions surrounding copyright levies […]
Redesign Of Ebola Treatment Units Draws 1500 Innovations, Including Locally 16/03/2015 by Hillary Muheebwa for Intellectual Property Watch 2 Comments KAMPALA, UGANDA – In light of the persistence of the Ebola outbreak and the demands it has placed on global infection containment resources and processes, the United States government disaster response community recognised an opportunity to use open innovation to make significant strides in advancing the ability to combat Ebola. The results include a local success story.
Are Generics Companies Using Inter Partes Review To Overturn Patent Court Cases? 13/03/2015 by William New, Intellectual Property Watch Leave a Comment NEW YORK – Will generics companies use a win under the new inter partes review mechanism in the United States to overturn pharmaceutical patents in court? A top attorney for a pharmaceutical innovator company says they could indeed. Meanwhile, a new analysis of the inter partes review so far shows it may not be as much of a cause for alarm as previously thought.